Clinical trial
Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's…
NCT00005867 · Lymphoma Trials Office, Other · Completed
Key facts
| NCT number | NCT00005867 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma |
| Official title | Phase III Trial Comparing CHOP ot PMitCEBO in Good Risk Patients With Histologically Aggresive Non Hodgkin's Lymphoma |
| Lead sponsor | Lymphoma Trials Office, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | bleomycin sulfate, CHOP regimen, cyclophosphamide, doxorubicin hydrochloride, etoposide, mitoxantrone hydrochloride, prednisolone, vincristine sulfate |
| Enrollment | 310 |
| Start date | Jan 1, 1998 |
| Completion | Aug 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 26, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: